Hwangryun-haedok-tang fermented with lactobacillus casei suppresses ovariectomy-induced bone loss

Ki Shuk Shim, Taesoo Kim, Hyunil Ha, Chang Won Cho, Hansung Kim, Dong Hyun Seo, Jin Yeul Ma

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Hwangryun-haedok-tang (HRT) is the common recipe in traditional Asian medicine, and microbial fermentation is used for the conventional methods for processing traditional medicine. We investigated the inhibitory effect of the n-butanol fraction of HRT (HRT-BU) and fHRT (fHRT-BU) on the RANKL-induced osteoclastogenesis in bone-marrow-derived macrophages. mRNA expression of osteoclastogenesis-related genes were evaluated by real-time QPCR. The activation of signaling pathways was determined by western blot analysis. The marker compounds of HRT-BU and fHRT-BU were analyzed by HPLC. The inhibitory effect of HRT or fHRT on ovariectomy-induced bone loss were evaluated using OVX rats with orally administered HRT, fHRT (300, 1000 mg/kg), or its vehicle for 12 weeks. fHRT-BU significantly inhibited RANKL-induced osteoclastogenesis, and phosphorylation of p38, IKKα/β, and NF-Bp65 compared to HRT-BU. In addition, fHRT-BU also significantly inhibited the mRNA expression of Nfb2, TNF-α, NFATc1, TRAP, ATPv0d2, and cathepsin K. Furthermore, administration of fHRT had a greater effect on the increase of BMD, and greater improved bone microstructure of the femora than that of HRT in ovariectomy rats. This study demonstrated that bacterial fermentation enhances the inhibitory effect of HRT on osteoclastogenesis and bone loss. These results suggest that fermented HRT might have the beneficial effects on bone disease by inhibiting osteoclastogenesis.

Original languageEnglish
Article number325791
JournalEvidence-based Complementary and Alternative Medicine
Volume2012
DOIs
Publication statusPublished - 2012 Dec 1

Fingerprint

Lactobacillus casei
Ovariectomy
Osteogenesis
Bone and Bones
Traditional Medicine
Fermentation
Cathepsin K
Messenger RNA
1-Butanol
Bone Diseases
Femur
Western Blotting
Macrophages
High Pressure Liquid Chromatography
Phosphorylation
Genes

All Science Journal Classification (ASJC) codes

  • Complementary and alternative medicine

Cite this

Shim, Ki Shuk ; Kim, Taesoo ; Ha, Hyunil ; Cho, Chang Won ; Kim, Hansung ; Seo, Dong Hyun ; Ma, Jin Yeul. / Hwangryun-haedok-tang fermented with lactobacillus casei suppresses ovariectomy-induced bone loss. In: Evidence-based Complementary and Alternative Medicine. 2012 ; Vol. 2012.
@article{738509ac52db41b8a09849738ea89eb3,
title = "Hwangryun-haedok-tang fermented with lactobacillus casei suppresses ovariectomy-induced bone loss",
abstract = "Hwangryun-haedok-tang (HRT) is the common recipe in traditional Asian medicine, and microbial fermentation is used for the conventional methods for processing traditional medicine. We investigated the inhibitory effect of the n-butanol fraction of HRT (HRT-BU) and fHRT (fHRT-BU) on the RANKL-induced osteoclastogenesis in bone-marrow-derived macrophages. mRNA expression of osteoclastogenesis-related genes were evaluated by real-time QPCR. The activation of signaling pathways was determined by western blot analysis. The marker compounds of HRT-BU and fHRT-BU were analyzed by HPLC. The inhibitory effect of HRT or fHRT on ovariectomy-induced bone loss were evaluated using OVX rats with orally administered HRT, fHRT (300, 1000 mg/kg), or its vehicle for 12 weeks. fHRT-BU significantly inhibited RANKL-induced osteoclastogenesis, and phosphorylation of p38, IKKα/β, and NF-Bp65 compared to HRT-BU. In addition, fHRT-BU also significantly inhibited the mRNA expression of Nfb2, TNF-α, NFATc1, TRAP, ATPv0d2, and cathepsin K. Furthermore, administration of fHRT had a greater effect on the increase of BMD, and greater improved bone microstructure of the femora than that of HRT in ovariectomy rats. This study demonstrated that bacterial fermentation enhances the inhibitory effect of HRT on osteoclastogenesis and bone loss. These results suggest that fermented HRT might have the beneficial effects on bone disease by inhibiting osteoclastogenesis.",
author = "Shim, {Ki Shuk} and Taesoo Kim and Hyunil Ha and Cho, {Chang Won} and Hansung Kim and Seo, {Dong Hyun} and Ma, {Jin Yeul}",
year = "2012",
month = "12",
day = "1",
doi = "10.1155/2012/325791",
language = "English",
volume = "2012",
journal = "Evidence-based Complementary and Alternative Medicine",
issn = "1741-427X",
publisher = "Hindawi Publishing Corporation",

}

Hwangryun-haedok-tang fermented with lactobacillus casei suppresses ovariectomy-induced bone loss. / Shim, Ki Shuk; Kim, Taesoo; Ha, Hyunil; Cho, Chang Won; Kim, Hansung; Seo, Dong Hyun; Ma, Jin Yeul.

In: Evidence-based Complementary and Alternative Medicine, Vol. 2012, 325791, 01.12.2012.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hwangryun-haedok-tang fermented with lactobacillus casei suppresses ovariectomy-induced bone loss

AU - Shim, Ki Shuk

AU - Kim, Taesoo

AU - Ha, Hyunil

AU - Cho, Chang Won

AU - Kim, Hansung

AU - Seo, Dong Hyun

AU - Ma, Jin Yeul

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Hwangryun-haedok-tang (HRT) is the common recipe in traditional Asian medicine, and microbial fermentation is used for the conventional methods for processing traditional medicine. We investigated the inhibitory effect of the n-butanol fraction of HRT (HRT-BU) and fHRT (fHRT-BU) on the RANKL-induced osteoclastogenesis in bone-marrow-derived macrophages. mRNA expression of osteoclastogenesis-related genes were evaluated by real-time QPCR. The activation of signaling pathways was determined by western blot analysis. The marker compounds of HRT-BU and fHRT-BU were analyzed by HPLC. The inhibitory effect of HRT or fHRT on ovariectomy-induced bone loss were evaluated using OVX rats with orally administered HRT, fHRT (300, 1000 mg/kg), or its vehicle for 12 weeks. fHRT-BU significantly inhibited RANKL-induced osteoclastogenesis, and phosphorylation of p38, IKKα/β, and NF-Bp65 compared to HRT-BU. In addition, fHRT-BU also significantly inhibited the mRNA expression of Nfb2, TNF-α, NFATc1, TRAP, ATPv0d2, and cathepsin K. Furthermore, administration of fHRT had a greater effect on the increase of BMD, and greater improved bone microstructure of the femora than that of HRT in ovariectomy rats. This study demonstrated that bacterial fermentation enhances the inhibitory effect of HRT on osteoclastogenesis and bone loss. These results suggest that fermented HRT might have the beneficial effects on bone disease by inhibiting osteoclastogenesis.

AB - Hwangryun-haedok-tang (HRT) is the common recipe in traditional Asian medicine, and microbial fermentation is used for the conventional methods for processing traditional medicine. We investigated the inhibitory effect of the n-butanol fraction of HRT (HRT-BU) and fHRT (fHRT-BU) on the RANKL-induced osteoclastogenesis in bone-marrow-derived macrophages. mRNA expression of osteoclastogenesis-related genes were evaluated by real-time QPCR. The activation of signaling pathways was determined by western blot analysis. The marker compounds of HRT-BU and fHRT-BU were analyzed by HPLC. The inhibitory effect of HRT or fHRT on ovariectomy-induced bone loss were evaluated using OVX rats with orally administered HRT, fHRT (300, 1000 mg/kg), or its vehicle for 12 weeks. fHRT-BU significantly inhibited RANKL-induced osteoclastogenesis, and phosphorylation of p38, IKKα/β, and NF-Bp65 compared to HRT-BU. In addition, fHRT-BU also significantly inhibited the mRNA expression of Nfb2, TNF-α, NFATc1, TRAP, ATPv0d2, and cathepsin K. Furthermore, administration of fHRT had a greater effect on the increase of BMD, and greater improved bone microstructure of the femora than that of HRT in ovariectomy rats. This study demonstrated that bacterial fermentation enhances the inhibitory effect of HRT on osteoclastogenesis and bone loss. These results suggest that fermented HRT might have the beneficial effects on bone disease by inhibiting osteoclastogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84874880674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874880674&partnerID=8YFLogxK

U2 - 10.1155/2012/325791

DO - 10.1155/2012/325791

M3 - Article

VL - 2012

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

SN - 1741-427X

M1 - 325791

ER -